Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)

6 Months Ended

Jun. 30, 2013

Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities

Schedule of marketable investment securities, restricted cash and other investment securities

	As of
	June 30,		December 31,
	2013		2012
	(In thousands)
Marketable investment securities:
Current marketable investment securities - VRDNs	$	154,131	$	130,306
Current marketable investment securities - strategic	1,363,460		1,261,015
Current marketable investment securities - other	3,915,749		2,240,316
Total current marketable investment securities	5,433,340		3,631,637
Restricted marketable investment securities (1)	84,777		51,366
Noncurrent marketable investment securities - ARS and other (2)	119,191		106,172
Total marketable investment securities	5,637,308		3,789,175
Restricted cash and cash equivalents (1)	6,081		83,044
Other investment securities:
Other investment securities - cost method (2)	15,104		12,879
Total other investment securities	15,104		12,879
Total marketable investment securities, restricted cash and cash equivalents, and other investment securities	$	5,658,493	$	3,885,098

(1) Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash and marketable investment securities” on our Condensed Consolidated Balance Sheets.

(2) Noncurrent marketable investment securities — auction rate securities (“ARS”) and other investment securities are included in “Marketable and other investment securities” on our Condensed Consolidated Balance Sheets.

Schedule of unrealized gain (loss) on marketable investment securities

	As of June 30, 2013										As of December 31, 2012
	Marketable										Marketable
	Investment		Unrealized								Investment		Unrealized
	Securities		Gains		Losses			Net			Securities		Gains		Losses			Net
	(In thousands)
Debt securities:
VRDNs	$	154,131	$	—	$	—		$	—		$	130,306	$	—	$	—		$	—
ARS and other	46,454		1,154		(4,485		)	(3,331		)	43,921		1,375		(8,033		)	(6,658		)
ARS fair value election	72,737		—		—			—			62,251		—		—			—
Other (including restricted)	4,927,741		174,293		(5,012		)	169,281			3,287,317		208,208		(1,203		)	207,005
Equity securities	436,245		74,203		(1,701		)	72,502			265,380		17,918		(11,537		)	6,381
Total	$	5,637,308	$	249,650	$	(11,198	)	$	238,452		$	3,789,175	$	227,501	$	(20,773	)	$	206,728

Schedule of available-for-sale securities in continuous unrealized loss position by length of time and their fair value

	As of
	June 30, 2013					December 31, 2012
	Fair		Unrealized			Fair		Unrealized
	Value		Loss			Value		Loss
	(In thousands)
Debt Securities:
Less than 12 months	$	2,811,860	$	(4,404	)	$	761,551	$	(909	)
12 months or more	91,334		(5,093		)	72,395		(8,327		)
Equity Securities:
Less than 12 months	52,460		(1,701		)	154,566		(11,537		)
12 months or more	—		—			—		—
Total	$	2,955,654	$	(11,198	)	$	988,512	$	(20,773	)

Schedule of fair value measurements

	As of
	June 30, 2013								December 31, 2012
	Total		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3
	(In thousands)
Cash equivalents (including restricted)	$	3,752,515	$	4,886	$	3,747,629	$	—	$	3,386,929	$	67,833	$	3,319,096	$	—
Debt securities:
VRDNs	$	154,131	$	—	$	154,131	$	—	$	130,306	$	—	$	130,306	$	—
ARS and other	119,191		—		807		118,384		106,172		—		955		105,217
Other (including restricted)	4,927,741		11,045		4,916,696		—		3,287,317		11,182		3,276,135		—
Equity securities	436,245		436,245		—		—		265,380		265,380		—		—
Subtotal	5,637,308		447,290		5,071,634		118,384		3,789,175		276,562		3,407,396		105,217
Purchases and prepaid funding of derivative financial instruments	780,531		103,985		676,546		—		—		—		—		—
Total	$	6,417,839	$	551,275	$	5,748,180	$	118,384	$	3,789,175	$	276,562	$	3,407,396	$	105,217

Schedule of changes in Level 3 instruments

	Level 3
	Investment
	Securities
	(In thousands)
Balance as of December 31, 2012	$	105,217
Net realized and unrealized gains (losses) included in earnings	10,565
Net realized and unrealized gains (losses) included in other comprehensive income (loss)	3,528
Purchases	—
Settlements	(926		)
Issuances	—
Transfers from level 2 to level 3	—
Balance as of June 30, 2013	$	118,384

Schedule of gains and losses on sales and changes in carrying values of investments

	For the Three Months					For the Six Months
	Ended June 30,					Ended June 30,
Other Income (Expense):	2013		2012			2013			2012
	(In thousands)
Marketable investment securities - gains (losses) on sales/exchanges	$	13,625	$	3,117		$	14,182		$	7,736
Marketable investment securities - unrealized gains (losses) on investments accounted for at fair value	6,220		(11,541		)	10,486			(3,062		)
Marketable investment securities - gains (losses) on conversion of DBSD North America Notes (1)	—		—			—			99,445
Derivative financial instruments - unrealized gains (losses) (2)	76,273		—			84,531			—
Marketable investment securities - other-than-temporary impairments	—		—			(1,919		)	(2,481		)
Other	1,123		976			(299		)	1,196
Total	$	97,241	$	(7,448	)	$	106,981		$	102,834

(1) During the six months ended June 30, 2012, we recognized a $99 million non-cash gain related to the conversion of our DBSD North America 7.5% Convertible Senior Secured Notes due 2009 in connection with the completion of the DBSD Transaction.

(2) During the three and six months ended June 30, 2013, we recorded unrealized gains of $76 million and $85 million, respectively, on our derivative financial instruments that are indexed to the trading price of the common equity securities of Sprint.